Let's Talk About PrEP

Let's Talk About PrEP

Update: 2022-09-20
Share

Description

Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are potential game changers in efforts to reduce the prevalence of HIV across the globe.  But uptake continues to be lackluster, especially in traditionally underserved populations.  Bruce and clinical HIV Pharmacist™ Dr. Carly Floyd discuss how PrEP has evolved over the last decade in clinical use for HIV prevention and share strategies for increasing PrEP and PEP access and uptake to populations that have not yet been adequately reached.

PrEP is available in both oral and injectable formulations and, when taken routinely can prevent the transmission of HIV, whether through blood, sexual exposure, or injection. PrEP and PEP are key pillars in the U.S. National HIV/AIDS Strategy to end the HIV epidemic.

About Dr. Floyd:

Dr. Floyd is a clinical pharmacist at Southwest Care Center in Albuquerque, New Mexico and clinical director of the University of New Mexico’s AIDS Education and Training Center.

Resources:

********

Questions about this topic? E-mail podcast@aahivm.org to get connected with Bruce or any of our guests.

Are you a medical provider and want to join the conversation? Make your voice heard in the Academy Communities and connect with other HIV clinicians!

To learn more about the Academy, visit www.aahivm.org

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Let's Talk About PrEP

Let's Talk About PrEP

American Academy of HIV Medicine